Coventry Health Care (CVH) Tops Q3 EPS by 12c; Increases FY Guidance Range
More News related to CVH
- Goldman Sachs Added Coventry Health Care (CVH) to its Conviction Sell List
- Coventry Health Care Elects Dr. Michael Stocker to Board of Directors
- Coventry Health Care (CVH) Tops Q3 EPS by 12c; Increases FY Guidance Range
- Coventry Health Care Reports Third Quarter Earnings and Increases Full Year 2009 Guidance
- Trading Radar for 10/30: Sony (SNE), Penske (PAG), Alcatel-Lucent (ALU) Report
Coventry Health Care, Inc. (NYSE: CVH) reports Q3 adjusted EPS of $0.66, 12 cents better than estimates. Revenues were $3.4 billion vs. $3.47 billion consensus.
Excluding the impact of the FHSC divestiture, the Company is increasing its full year 2009 adjusted EPS guidance to a range of $2.01 to $2.03, an increase of $0.12 from the midpoint of the prior EPS range of $1.85 to $1.95. (Consensus is $1.91)
[SM]
Related Categories
EarningsGuidance
Stocks Mentioned
-0.36Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
